Maria Gabriella Camboni
Chief Executive Officer at Nephris Srl
Profile
Maria Gabriella Camboni is the founder of EOS SpA, which was founded in 2006.
She held the title of Vice President-Development from 2006 to 2009.
Dr. Camboni is also the founder of Novuspharma SpA.
Currently, she is the Chief Executive Officer & Director at Nephris Srl, Chairman at Amypopharma Srl, and Non-Executive Director at MISSION Therapeutics Ltd.
In the past, she worked as the Chief Executive Officer & Director at PinCell Srl from 2020 to 2022.
She also worked as an Independent Director at Stallergenes SA, Head-Medical Affairs Europe at Novartis Oncology, Inc., Clinical Project Leader at Sandoz SpA, and Head-Clinical Oncology at Boehringer Mannheim Corp.
(California).
Dr. Camboni holds a doctorate degree from the University of Milan.
Maria Gabriella Camboni active positions
Companies | Position | Start |
---|---|---|
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Amypopharma Srl
Amypopharma Srl BiotechnologyHealth Technology Amypopharma Srl develops therapeutic solutions for protein disorders. It specializes in functionalized nanoliposomes to treat protein misfolding disorders. The company was founded by Massimo Ernesto Masserini and Francesca Re in 2015 and is headquartered in Milan, Italy. | Chairman | - |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Nephris Srl provides pre-clinical and research services for kidney diseases. The company is based in Milan, Italy. The Italian company was founded in 2021 by Paolo Fiorina, Francesca D'Addio. The CEO is Maria Gabriella Camboni. | Chief Executive Officer | - |
Former positions of Maria Gabriella Camboni
Companies | Position | End |
---|---|---|
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Chief Executive Officer | 19/01/2022 |
Novuspharma SpA | Founder | 27/07/2011 |
Boehringer Mannheim Corp. (California) | Corporate Officer/Principal | - |
Sandoz SpA
Sandoz SpA Pharmaceuticals: MajorHealth Technology Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy. | Corporate Officer/Principal | - |
STALLERGENES | Director/Board Member | - |
Training of Maria Gabriella Camboni
University of Milan | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 10 |
---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novuspharma SpA | Health Technology |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy. | Health Technology |
Sandoz SpA
Sandoz SpA Pharmaceuticals: MajorHealth Technology Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy. | Health Technology |
Boehringer Mannheim Corp. (California) | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Amypopharma Srl
Amypopharma Srl BiotechnologyHealth Technology Amypopharma Srl develops therapeutic solutions for protein disorders. It specializes in functionalized nanoliposomes to treat protein misfolding disorders. The company was founded by Massimo Ernesto Masserini and Francesca Re in 2015 and is headquartered in Milan, Italy. | Health Technology |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Health Technology |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Nephris Srl provides pre-clinical and research services for kidney diseases. The company is based in Milan, Italy. The Italian company was founded in 2021 by Paolo Fiorina, Francesca D'Addio. The CEO is Maria Gabriella Camboni. | Commercial Services |
- Stock Market
- Insiders
- Maria Gabriella Camboni